Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

计划入组 64 人 · 首次发布于 2025 年 12 月 11 日

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients

计划入组 130 人 · 首次发布于 2012 年 12 月 10 日

MCG In Long QT Syndrome

计划入组 100 人 · 首次发布于 2025 年 12 月 8 日

QT-0101

PEC QT

ALPORT SYNDROME FOUNDATION

United States

QT INSTRUMENTS (S) PTE LTD

Singapore

International Rett Syndrome Foundation

United States

Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation

Thryv Therapeutics licenses structurally distinct SGK1 inhibitors to expand into Parkinson's and Alzheimer's disease

Thryv Therapeutics Unveils Breakthrough SGK1 Inhibitor Data for Heart Failure and Long QT Syndrome at ESC Congress 2025